Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme

DrugDrug NameDrug Indication
DB00103Agalsidase betaFor treatment of Fabry's disease (alpha-galactosidase A deficiency)
DrugDrug NameTargetType
DB00103Agalsidase betaGlobotriaosylceramidetarget